P-053: A systematic review of measurable residual disease (MRD) assessment characteristics in myeloma trials from 2015-2020

Skip to main content

Open Access Publications from the University of California

P-053: A systematic review of measurable residual disease (MRD) assessment characteristics in myeloma trials from 2015-2020

2022

Published Web Location

https://doi.org/10.1016/s2152-2650(22)00383-4

Creative Commons 'BY' version 4.0 license

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.